Search for: "ABBOTT v. ABBOTT"
Results 1681 - 1700
of 2,570
Sort by Relevance
|
Sort by Date
22 Mar 2011, 4:21 pm
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly… well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany:… [read post]
20 Mar 2011, 8:05 pm
In Millet v. [read post]
18 Mar 2011, 9:55 pm
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "Antibody Patents after Centocor" on Wednesday, March 23, 2011 beginning at 2:00 PM (ET). [read post]
17 Mar 2011, 11:55 am
Centocor Ortho Biotech v. [read post]
17 Mar 2011, 12:31 am
Abbott Labs., 339 F.3d 1324, 1329 (Fed. [read post]
16 Mar 2011, 3:50 am
(Kluwer Patent Blog) US: Abraxis Biosciences v Navinta en banc denied – looking back to DBB, forward to Stanford/Roche (IPBiz) US: W D Washington denies preliminary injunction in biotech trademark dispute: Mirina Corp. v Marina Biotech (Seattle Trademark Lawyer) US: Issues to consider when structuring medical device development and license agreements (IP Spotlight) US: Have you benefited from public access to PubMed? [read post]
15 Mar 2011, 8:59 pm
Abbott v. [read post]
14 Mar 2011, 4:25 pm
Supreme Court case of Abbot v. [read post]
9 Mar 2011, 3:00 am
Highlights this week included: Supreme Court shuts another door on patent settlement agreement antitrust challenge – denies certiorari in Cipro case: Louisiana Wholesale Drug Co. v. [read post]
8 Mar 2011, 1:23 pm
Cir. 2009) (en banc in part) Abbott Laboratories v. [read post]
7 Mar 2011, 1:35 pm
., et al. v. [read post]
7 Mar 2011, 8:45 am
International Church of the Foursquare Gospel v. [read post]
4 Mar 2011, 9:18 pm
(Gray on Claims) (Maier & Maier) (Docket Report) (Inventive Step) Humira (Adalimumab) – US: $1.67B verdict overturned by CAFC, patent invalidated over written description: Centocor v Abbott / Humira??????? [read post]
3 Mar 2011, 10:13 am
Filed February 15, 2011, by Abbott. [read post]
3 Mar 2011, 10:13 am
Filed February 15, 2011, by Abbott. [read post]
1 Mar 2011, 8:38 pm
Highlights this week included: Humira (Adalimumab) – US: $1.67B verdict overturned by CAFC, patent invalidated over written description: Centocor v Abbott (Peter Zura’s 271 Patent Blog) (Patently-O) (Patently-O) (Patent Law Practice Center) (Patent Docs) (IPBiz) Fexofenadine – Australia: Anti-histamine inventive… but not novel, says Federal Court! [read post]
1 Mar 2011, 2:04 pm
Trades Council v. [read post]
1 Mar 2011, 11:16 am
Walker is an associate at Abbott & Kindermann, LLP. [read post]
28 Feb 2011, 12:41 pm
Id.; Veltri v. [read post]
28 Feb 2011, 8:19 am
The court further quoted from Regents of the Univ. of Cal. v. [read post]
